SK19199A3 - Bicyclic pyrimidine derivatives and their use as anti-coagulants - Google Patents

Bicyclic pyrimidine derivatives and their use as anti-coagulants Download PDF

Info

Publication number
SK19199A3
SK19199A3 SK191-99A SK19199A SK19199A3 SK 19199 A3 SK19199 A3 SK 19199A3 SK 19199 A SK19199 A SK 19199A SK 19199 A3 SK19199 A3 SK 19199A3
Authority
SK
Slovakia
Prior art keywords
group
alkyl
optionally substituted
nitro
cyanophenoxy
Prior art date
Application number
SK191-99A
Other languages
English (en)
Slovak (sk)
Inventor
Michael M Morrissey
Brad Buckman
Raju Mohan
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SK19199A3 publication Critical patent/SK19199A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/02Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SK191-99A 1996-08-16 1997-08-14 Bicyclic pyrimidine derivatives and their use as anti-coagulants SK19199A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/699,372 US5693641A (en) 1996-08-16 1996-08-16 Bicyclic pyrimidine derivatives and their use as anti-coagulants
PCT/EP1997/004444 WO1998007723A1 (fr) 1996-08-16 1997-08-14 Derives de la pyrimidine bicyclique et leur utilisation comme anti-coagulants

Publications (1)

Publication Number Publication Date
SK19199A3 true SK19199A3 (en) 1999-07-12

Family

ID=24809035

Family Applications (1)

Application Number Title Priority Date Filing Date
SK191-99A SK19199A3 (en) 1996-08-16 1997-08-14 Bicyclic pyrimidine derivatives and their use as anti-coagulants

Country Status (21)

Country Link
US (3) US5693641A (fr)
EP (1) EP0922045B1 (fr)
JP (1) JP2000516241A (fr)
KR (1) KR20000068173A (fr)
CN (1) CN1112363C (fr)
AT (1) ATE237617T1 (fr)
AU (1) AU724413B2 (fr)
CA (1) CA2261908A1 (fr)
CZ (1) CZ297323B6 (fr)
DE (1) DE69721008T2 (fr)
DK (1) DK0922045T3 (fr)
ES (1) ES2195163T3 (fr)
IL (1) IL128062A0 (fr)
NO (1) NO990708L (fr)
NZ (1) NZ333774A (fr)
PL (1) PL331634A1 (fr)
PT (1) PT922045E (fr)
RU (1) RU2198884C2 (fr)
SK (1) SK19199A3 (fr)
UA (1) UA59370C2 (fr)
WO (1) WO1998007723A1 (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE251141T1 (de) 1995-03-10 2003-10-15 Berlex Lab Benzamidin-derivate, deren herstellung und deren verwendung als anti-koagulantien
US5994375A (en) 1996-02-12 1999-11-30 Berlex Laboratories, Inc. Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants
ATE228513T1 (de) 1996-09-12 2002-12-15 Schering Ag Durch cyclische aminosäuren oder cyclische hydroxysäuren substituierte benzamidinderivate und deren verwendung als antikoagulantien
US6004985A (en) * 1996-10-09 1999-12-21 Berlex Laboratories, Inc. Thio acid derived monocylic N-heterocyclics as anticoagulants
US6686364B2 (en) 1997-12-08 2004-02-03 Berlex Laboratories, Inc. Benzamidine derivatives and their use as anti-coagulants
US6140351A (en) * 1997-12-19 2000-10-31 Berlex Laboratories, Inc. Ortho-anthranilamide derivatives as anti-coagulants
EP1040108B1 (fr) 1997-12-19 2004-02-25 Schering Aktiengesellschaft Derives d'ortho-anthranilamide comme anticoagulants
US6262088B1 (en) * 1998-11-19 2001-07-17 Berlex Laboratories, Inc. Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
US6127376A (en) 1998-12-04 2000-10-03 Berlex Laboratories, Inc. Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
WO2000038683A1 (fr) 1998-12-23 2000-07-06 Du Pont Pharmaceuticals Company INHIBITEURS DU FACTEUR Xa OU DE LA THROMBINE
US6350761B1 (en) 1999-07-30 2002-02-26 Berlex Laboratories, Inc. Benzenamine derivatives as anti-coagulants
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
WO2003059884A1 (fr) 2001-12-21 2003-07-24 X-Ceptor Therapeutics, Inc. Modulateurs de lxr
DE10239821A1 (de) * 2002-08-29 2004-03-11 Roche Diagnostics Gmbh Verbesserung der Spezifität bei der Bestimmung von Antithrombin
AU2003302238A1 (en) 2002-12-03 2004-06-23 Axys Pharmaceuticals, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
US7176196B2 (en) * 2004-05-28 2007-02-13 Bristol-Myers Squibb Company Bicyclic heterocycles as HIV integrase inhibitors
ATE543819T1 (de) * 2006-10-19 2012-02-15 Signal Pharm Llc Heteroarylverbindungen, zusammensetzungen daraus und behandlungsverfahren damit
US8383654B2 (en) * 2008-11-17 2013-02-26 Panmira Pharmaceuticals, Llc Heterocyclic antagonists of prostaglandin D2 receptors
ES2467108T3 (es) 2008-12-09 2014-06-11 Gilead Sciences, Inc. Moduladores de receptores tipo toll
NO2477987T3 (fr) * 2009-09-14 2018-06-09
CN103180318B (zh) 2010-05-14 2017-05-10 达那-法伯癌症研究所 雄性避孕组合物以及使用方法
US9714946B2 (en) 2013-03-14 2017-07-25 Dana-Farber Cancer Institute, Inc. Bromodomain binding reagents and uses thereof
WO2014182822A1 (fr) 2013-05-07 2014-11-13 St. Jude Medical, Atrial Fibrillation Division, Inc. Utilisation d'agencements spatiaux d'électrodes pour caractériser des états de conduction cardiaque
AU2014292888B2 (en) 2013-07-25 2018-03-22 Dana-Farber Cancer Institute, Inc. Inhibitors of transcription factors and uses thereof
CA2929652A1 (fr) 2013-11-08 2015-05-14 Dana-Farber Cancer Institute, Inc. Polytherapie pour le traitement du cancer utilisant des inhibiteurs de proteine a bromodomaine et a domaine extra-terminal (bet)
WO2015117087A1 (fr) 2014-01-31 2015-08-06 Dana-Farber Cancer Institute, Inc. Utilisations des dérivés de diazépane
BR112016017045A2 (pt) 2014-01-31 2017-08-08 Dana Farber Cancer Inst Inc Derivados de diazepano e usos dos mesmos
CA2936865A1 (fr) 2014-01-31 2015-08-06 Dana-Farber Cancer Institute, Inc. Derives de diaminopyrimidine benzenesulfone et leurs utilisations
SG11201607108XA (en) 2014-02-28 2016-09-29 Tensha Therapeutics Inc Treatment of conditions associated with hyperinsulinaemia
PT3166607T (pt) 2014-07-11 2022-12-07 Gilead Sciences Inc Moduladores de receptores de tipo toll para o tratamento do vih
KR20170032474A (ko) * 2014-08-08 2017-03-22 다나-파버 캔서 인스티튜트 인크. 디히드로프테리디논 유도체 및 그의 용도
CN106715437A (zh) 2014-08-08 2017-05-24 达纳-法伯癌症研究所股份有限公司 二氮杂环庚烷衍生物及其用途
BR112017005100A2 (pt) 2014-09-16 2017-12-05 Gilead Sciences Inc métodos de preparação de moduladores de receptores do tipo toll
CA2960436C (fr) 2014-09-16 2021-01-05 Gilead Sciences, Inc. Formes solides d'un modulateur de recepteurs de type toll
BR112017008714A2 (pt) 2014-10-27 2017-12-19 Tensha Therapeutics Inc inibidores de bromodomínio
US10702527B2 (en) 2015-06-12 2020-07-07 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
RU2018112953A (ru) 2015-09-11 2019-10-14 Дана-Фарбер Кэнсер Инститьют, Инк. Ацетамидтиенотриазолодиазепины и пути их применения
HK1256417A1 (zh) 2015-09-11 2019-09-20 达纳-法伯癌症研究所股份有限公司 氰基噻吩并三唑并二氮杂环庚三烯及其用途
MX2018006499A (es) 2015-11-25 2018-08-01 Dana Farber Cancer Inst Inc Inhibidores de bromodominio bivalentes y usos de los mismos.
AU2020300002A1 (en) 2019-07-01 2022-02-24 Tonix Pharma Limited Anti-CD154 antibodies and uses thereof
US20240059781A1 (en) 2021-01-06 2024-02-22 Tonix Pharma Limited Methods of inducing immune tolerance with modified anti-cd154 antibodies
WO2025248134A1 (fr) 2024-05-31 2025-12-04 Tonix Pharma Limited Méthodes de traitement comprenant l'administration d'anticorps cd154 modifiés

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1297100C (fr) * 1986-08-28 1992-03-10 Ryuji Niwa Medicament contre l'arteriosclerose, contenant un derive de la pyrimido [2,1-b]-benzothiazole
AU666318B2 (en) * 1991-06-28 1996-02-08 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
ZA928276B (en) * 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
DE69321344D1 (de) * 1992-02-14 1998-11-05 Corvas Int Inc Inhibitoren der thrombose
DE4213919A1 (de) * 1992-04-28 1993-11-04 Thomae Gmbh Dr K Cyclische iminoderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
AU675981B2 (en) * 1992-12-02 1997-02-27 Bristol-Myers Squibb Company Guanidinyl-substituted heterocyclic thrombin inhibitors
CA2151044A1 (fr) * 1992-12-15 1994-06-23 Terence K. Brunck Nouveaux inhibiteurs pour le facteur xa
US5332822A (en) * 1992-12-24 1994-07-26 Bristol-Myers Squibb Company Heteroaromatic and thioheteroaromatic substituted sulfonamide thrombin inhibitors
ATE181334T1 (de) * 1993-02-12 1999-07-15 Corvas Int Inc Inhibitoren gegen thrombose
IL115420A0 (en) * 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives

Also Published As

Publication number Publication date
CZ297323B6 (cs) 2006-11-15
PL331634A1 (en) 1999-08-02
RU2198884C2 (ru) 2003-02-20
ES2195163T3 (es) 2003-12-01
KR20000068173A (ko) 2000-11-25
PT922045E (pt) 2003-07-31
CZ50199A3 (cs) 1999-06-16
AU4015697A (en) 1998-03-06
US5846970A (en) 1998-12-08
DE69721008T2 (de) 2003-12-24
UA59370C2 (uk) 2003-09-15
DK0922045T3 (da) 2003-06-30
HK1020058A1 (en) 2000-03-10
US5846972A (en) 1998-12-08
NO990708D0 (no) 1999-02-15
NZ333774A (en) 2000-08-25
EP0922045B1 (fr) 2003-04-16
EP0922045A1 (fr) 1999-06-16
IL128062A0 (en) 1999-11-30
DE69721008D1 (de) 2003-05-22
CN1227553A (zh) 1999-09-01
CN1112363C (zh) 2003-06-25
NO990708L (no) 1999-04-15
ATE237617T1 (de) 2003-05-15
WO1998007723A1 (fr) 1998-02-26
US5693641A (en) 1997-12-02
JP2000516241A (ja) 2000-12-05
CA2261908A1 (fr) 1998-02-26
AU724413B2 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
SK19199A3 (en) Bicyclic pyrimidine derivatives and their use as anti-coagulants
SK19399A3 (en) Purine derivatives and their use as anti-coagulants
AU760370B2 (en) Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
SK46499A3 (en) Thio acid derived monocyclic n-heterocyclics as anticoagulants
SK29599A3 (en) Benzamidine derivatives substituted by cyclic amino acid or cyclic hydroxy acid derivatives and their use as anti-coagulants
SK283306B6 (sk) Benzamidínové deriváty substituované aminokyselinovými alebo hydroxykyselinovými derivátmi, farmaceutický prostriedok obsahujúci tieto deriváty a ich použitie